{"entity":{"id":"surgical-resection-specimen","kind":"term","name":"Surgical resection specimen","aka":[],"tldr":"Removed tissue becomes interpretable through documented orientation and sampling that link microscopic and molecular findings to their locations.","summary":"A resection specimen is removed tissue submitted for examination. The laboratory documents gross features, marks relevant surfaces and maps selected regions into labelled blocks. Microscopy and additional assays describe the represented material, rather than every cell remaining in the body.","asOf":"2026-11-10","links":[{"label":"CAP practical breast grossing guide excerpt","url":"https://documents-cloud.cap.org/pdf/Grossing_Sample.pdf"}],"tags":[],"related":["core-needle-biopsy","h-and-e-staining","tumour-purity","biopsy"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Keep the specimen site, procedure, prior treatment, orientation key, surface inks, cassette map and tested block with the result. Ink colours have a local documented meaning. Gross specimen dimensions are not automatically invasive tumour dimensions. Fragmentation or ink entering cracks can complicate surface interpretation.","Fictional example: block A is central lesion and block B is a superior surface. A sequencing result from block A cannot be assigned to block B merely because both came from one operation. An additional test needs its own block identity and preservation history.","Resection supports assessment of represented tumour extent, surfaces, sampled nodes and treatment effect. A large specimen is not automatically examined cell by cell in its entirety. Collection time and preceding treatment define the biological time point, so a post-treatment resection cannot substitute for a pretreatment biopsy.","Diagnostic orientation and mapped sampling must remain intact when additional material is allocated. A research aliquot needs its site, block, preservation, treatment context and permissions. Slide counts alone do not establish the completeness of representation; a clear examined margin does not settle every clinical question.","Resection examination follows receipt and orientation, gross description, block mapping, microscopic examination and integration of findings. Record the named specimen and separately submitted parts; sectioning and extraction consume finite material. Depending on the cancer, specimen and treatment setting, outputs include diagnoses, dimensions and distances in millimetres, described margins and sampled-node counts. Lost orientation, fragmentation, ink penetration, incomplete mapping and unsuitable preservation can limit interpretation. Applicable diagnostic protocols and clinical correlation govern the report, while a research aliquot needs its own provenance. No specimen report examines every tissue left in the body or every unsampled node, or supplies an individual recurrence probability."],"category":"Pathology"},"route":"/terms/surgical-resection-specimen/","neighbours":{"term":[{"id":"biopsy","kind":"term","name":"Biopsy","route":"/terms/biopsy/"},{"id":"core-needle-biopsy","kind":"term","name":"Core needle biopsy and fine-needle aspiration (FNA)","route":"/terms/core-needle-biopsy/"},{"id":"h-and-e-staining","kind":"term","name":"H&E staining (haematoxylin and eosin)","route":"/terms/h-and-e-staining/"},{"id":"tumour-purity","kind":"term","name":"Tumour purity","route":"/terms/tumour-purity/"},{"id":"biopsy-after-neoadjuvant-therapy","kind":"term","name":"Tumour-bed biopsy after neoadjuvant therapy","route":"/terms/biopsy-after-neoadjuvant-therapy/"}],"technology":[{"id":"vacuum-assisted-breast-biopsy","kind":"technology","name":"Vacuum-assisted breast biopsy systems (Mammotome, EnCor, Eviva, Brevera)","route":"/technologies/vacuum-assisted-breast-biopsy/"}]}}